Singapore markets open in 8 hours 26 minutes
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,021.98 -13.71 (-0.27%) Dow
37,925.06 +109.14 (+0.29%) Nasdaq
15,601.42 -56.40 (-0.36%) Bitcoin USD
57,225.34 -3,014.92 (-5.00%) CMC Crypto 200
1,190.35 -148.71 (-11.12%)
Aadi Bioscience, Inc. (AADI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 12:34PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 47.14M |
| Enterprise value | -60.43M |
| Trailing P/E | 1.89 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.12 |
| Price/book (mrq) | 0.45 |
| Enterprise value/revenue | -2.48 |
| Enterprise value/EBITDA | 0.92 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.30 |
| 52-week change 3 | -75.16% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 8.6000 |
| 52-week low 3 | 1.5500 |
| 50-day moving average 3 | 2.0409 |
| 200-day moving average 3 | 3.6714 |
Share statistics
| Avg vol (3-month) 3 | 345.72k |
| Avg vol (10-day) 3 | 168.79k |
| Shares outstanding 5 | 24.55M |
| Implied shares outstanding 6 | 24.55M |
| Float 8 | 15.9M |
| % held by insiders 1 | 12.45% |
| % held by institutions 1 | 52.80% |
| Shares short (15 Apr 2024) 4 | 1.1M |
| Short ratio (15 Apr 2024) 4 | 4.46 |
| Short % of float (15 Apr 2024) 4 | 6.82% |
| Short % of shares outstanding (15 Apr 2024) 4 | 4.48% |
| Shares short (prior month 15 Mar 2024) 4 | 1.13M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 27 Aug 2021 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -270.04% |
| Operating margin (ttm) | -280.02% |
Management effectiveness
| Return on assets (ttm) | -28.40% |
| Return on equity (ttm) | -49.90% |
Income statement
| Revenue (ttm) | 24.35M |
| Revenue per share (ttm) | 0.90 |
| Quarterly revenue growth (yoy) | 21.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -71.76M |
| Net income avi to common (ttm) | -65.77M |
| Diluted EPS (ttm) | -2.4400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 108.84M |
| Total cash per share (mrq) | 4.43 |
| Total debt (mrq) | 1.27M |
| Total debt/equity (mrq) | 1.20% |
| Current ratio (mrq) | 4.72 |
| Book value per share (mrq) | 4.28 |
Cash flow statement
| Operating cash flow (ttm) | -59.66M |
| Levered free cash flow (ttm) | -37.7M |
© 2024 Yahoo. All rights reserved.